Comparison of the pharmacokinetics and tolerability of amlodipine + valsartan, amlodipine + hydrochlorothiazide, valsartan + hydrochlorothiazide, and amlodipine + valsartan + hydrochlorothiazide in patients with hypertension.

Trial Profile

Comparison of the pharmacokinetics and tolerability of amlodipine + valsartan, amlodipine + hydrochlorothiazide, valsartan + hydrochlorothiazide, and amlodipine + valsartan + hydrochlorothiazide in patients with hypertension.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2012

At a glance

  • Drugs Amlodipine; Hydrochlorothiazide; Valsartan
  • Indications Hypertension
  • Focus Pharmacokinetics
  • Sponsors Novartis Pharmaceuticals Corporation
  • Most Recent Events

    • 25 Apr 2012 Population pharmacokinetic analysis of hydrochlorothiazide presented at the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 13 Jan 2011 New trial record
    • 17 Sep 2010 Results published in the Journal of Clinical Pharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top